- Pharma year in review: The case for getting smaller
- US Capitol Capsule: Getting startups out of the lab: NIH's experiment
- AZ-Pfizer relief: 'at risk' partnerships in the clear as takeover plans fold
- US Capitol Capsule: Rare disease sector matures; FDA keeping pace?
COMMENT Other Informa Comment